Table 4.

Treatment Results

Evaluable patients  60  
CR  56  
PR  1  
Progress 14-150 
Death during therapy  1  
Cessation of therapy and death  1 
Evaluable patients  60  
CR  56  
PR  1  
Progress 14-150 
Death during therapy  1  
Cessation of therapy and death  1 
F4-150

Patient developed NHL.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal